Journal of Stroke · 2024 · 16 citations · 49 references
MedicineNeurologyNeuroscienceBiomedical ImagingDiagnostic ImagingNeuropathologyCerebrovascular DiseaseCerebrovascular ImagingNeurovascular ImagingStrokeStroke ImagingVascular ImagingAmyloid PlaquesCerebral Amyloid Angiopathy BiomarkersCerebral ArteriopathyCerebral Small Vessel Disease ImagingCerebral VasculopathyVascular Amyloidosis
Cerebral amyloid angiopathy (CAA) has been proven to be the most common pathological change in cerebral small vessel disease except arteriosclerosis. In recent years, with the discovery of imaging technology and new imaging markers, the diagnostic rate of CAA has greatly improved. CAA plays an important role in non-hypertensive cerebral hemorrhage and cognitive decline. This review comprehensively describes the etiology, epidemiology, pathophysiological mechanisms, clinical features, imaging manifestations, imaging markers, diagnostic criteria, and treatment of CAA to facilitate its diagnosis and treatment and reduce mortality.
49
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
J. Claude Hemphill, Steven M. Greenberg, Craig S. Anderson et al. · Stroke · 2015 · 4K citations
Medicine, Neurology, Neurosurgery +12
APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
Axel Montagne, Daniel A. Nation, Abhay P. Sagare et al. · Nature · 2020 · 1.3K citations · Full text
Medicine, Neurology, Neuroscience +14
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy
Jennifer Linn, Amy Halpin, Philippe Demaerel et al. · Neurology · 2010 · 920 citations
Prevalence and risk factors of cerebral microbleeds
Meike W. Vernooij, Aad van der Lugt, M. Arfan Ikram et al. · Neurology · 2008 · 789 citations